While our data provides genetic evidence that reducing endogenous HDAC6 levels protects against memory impairment in an AD mouse model, it remains to be tested whether pharmacological inhibition of HDAC6 would have similar effects. The gene discussed is HDAC6; the disease is memory impairment.